| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsid Proteins | 11 | 2015 | 67 | 1.290 |
Why?
|
| Oncogene Proteins, Viral | 10 | 2015 | 25 | 1.240 |
Why?
|
| Papillomavirus Vaccines | 8 | 2015 | 151 | 1.040 |
Why?
|
| Acetyltransferases | 4 | 2004 | 27 | 0.960 |
Why?
|
| Papillomavirus Infections | 10 | 2015 | 336 | 0.910 |
Why?
|
| Histone Acetyltransferases | 6 | 2007 | 19 | 0.830 |
Why?
|
| Transcription Factors | 6 | 2018 | 681 | 0.740 |
Why?
|
| Papillomaviridae | 7 | 2012 | 127 | 0.720 |
Why?
|
| Cell Cycle Proteins | 3 | 2007 | 229 | 0.680 |
Why?
|
| Human papillomavirus 16 | 7 | 2013 | 35 | 0.590 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 122 | 0.510 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2017 | 88 | 0.490 |
Why?
|
| Enzyme Inhibitors | 6 | 2010 | 433 | 0.490 |
Why?
|
| Histones | 4 | 2009 | 190 | 0.480 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2019 | 63 | 0.460 |
Why?
|
| Drug Discovery | 1 | 2014 | 82 | 0.450 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 133 | 0.440 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 935 | 0.430 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 295 | 0.420 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 312 | 0.410 |
Why?
|
| Animals | 29 | 2023 | 15081 | 0.400 |
Why?
|
| Adjuvants, Immunologic | 4 | 2015 | 107 | 0.390 |
Why?
|
| Mice | 20 | 2023 | 5913 | 0.390 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 578 | 0.380 |
Why?
|
| Chromatin | 4 | 2023 | 169 | 0.380 |
Why?
|
| Hela Cells | 6 | 2014 | 366 | 0.380 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 33 | 0.370 |
Why?
|
| Antibodies, Viral | 8 | 2015 | 262 | 0.370 |
Why?
|
| Saponins | 2 | 2015 | 6 | 0.370 |
Why?
|
| Humans | 41 | 2024 | 37093 | 0.370 |
Why?
|
| Repressor Proteins | 4 | 2015 | 249 | 0.370 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 3 | 0.360 |
Why?
|
| Ellagic Acid | 1 | 2009 | 4 | 0.360 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2010 | 277 | 0.350 |
Why?
|
| Arginine | 1 | 2009 | 73 | 0.340 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 1568 | 0.320 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 1180 | 0.320 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 3 | 0.300 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 1502 | 0.290 |
Why?
|
| Trans-Activators | 2 | 2005 | 174 | 0.290 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 213 | 0.280 |
Why?
|
| Female | 28 | 2023 | 20969 | 0.280 |
Why?
|
| Kinetics | 4 | 2014 | 708 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 807 | 0.270 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 307 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 187 | 0.260 |
Why?
|
| Neoplasms | 4 | 2019 | 1103 | 0.260 |
Why?
|
| Acetylation | 4 | 2007 | 98 | 0.260 |
Why?
|
| Neutralization Tests | 6 | 2013 | 53 | 0.250 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 2231 | 0.250 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2016 | 34 | 0.240 |
Why?
|
| Anacardic Acids | 2 | 2005 | 2 | 0.240 |
Why?
|
| Terpenes | 1 | 2004 | 28 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 408 | 0.230 |
Why?
|
| Curcumin | 1 | 2004 | 74 | 0.230 |
Why?
|
| Prostatic Hyperplasia | 1 | 2024 | 34 | 0.230 |
Why?
|
| Metabolome | 3 | 2019 | 53 | 0.230 |
Why?
|
| Salicylates | 1 | 2003 | 9 | 0.220 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 12 | 0.220 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 803 | 0.220 |
Why?
|
| Virion | 3 | 2012 | 69 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1015 | 0.220 |
Why?
|
| Mice, Nude | 4 | 2021 | 337 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 111 | 0.220 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 39 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 7 | 2015 | 661 | 0.210 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 93 | 0.210 |
Why?
|
| Receptors, Calcitriol | 1 | 2023 | 69 | 0.210 |
Why?
|
| Quinolines | 1 | 2022 | 64 | 0.210 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2007 | 10 | 0.200 |
Why?
|
| Benzylidene Compounds | 1 | 2021 | 5 | 0.200 |
Why?
|
| Models, Molecular | 4 | 2010 | 808 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 211 | 0.190 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 14 | 0.180 |
Why?
|
| Rabbits | 5 | 2013 | 283 | 0.180 |
Why?
|
| Molecular Structure | 3 | 2009 | 492 | 0.180 |
Why?
|
| Viral Vaccines | 2 | 2012 | 29 | 0.180 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 1 | 0.180 |
Why?
|
| Cisplatin | 2 | 2023 | 72 | 0.180 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 2 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2019 | 29 | 0.170 |
Why?
|
| Disease Progression | 3 | 2019 | 601 | 0.170 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 33 | 0.170 |
Why?
|
| Cell Line | 4 | 2011 | 1354 | 0.170 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 27 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1039 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2021 | 1198 | 0.160 |
Why?
|
| Antibodies, Neutralizing | 4 | 2015 | 109 | 0.160 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 156 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2019 | 127 | 0.160 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 13 | 0.150 |
Why?
|
| Apoptosis | 6 | 2021 | 1398 | 0.150 |
Why?
|
| Femur Head Necrosis | 1 | 2017 | 1 | 0.150 |
Why?
|
| Epitopes | 4 | 2013 | 148 | 0.150 |
Why?
|
| DNA Methylation | 2 | 2018 | 325 | 0.150 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 126 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 290 | 0.140 |
Why?
|
| Mutagens | 1 | 2017 | 69 | 0.140 |
Why?
|
| Carcinogens | 1 | 2017 | 124 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 128 | 0.140 |
Why?
|
| Papillomavirus E7 Proteins | 3 | 2015 | 11 | 0.140 |
Why?
|
| Male | 11 | 2024 | 20025 | 0.130 |
Why?
|
| Mitochondria | 1 | 2019 | 487 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2009 | 213 | 0.130 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 219 | 0.130 |
Why?
|
| Vagina | 2 | 2013 | 81 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 352 | 0.130 |
Why?
|
| Felodipine | 1 | 2014 | 1 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 159 | 0.120 |
Why?
|
| Binding, Competitive | 1 | 2014 | 111 | 0.120 |
Why?
|
| Protein Transport | 2 | 2014 | 302 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 172 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 29 | 0.120 |
Why?
|
| Surface Properties | 1 | 2014 | 130 | 0.120 |
Why?
|
| Piperidones | 1 | 2013 | 9 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 201 | 0.110 |
Why?
|
| Metabolomics | 3 | 2019 | 81 | 0.110 |
Why?
|
| Nogalamycin | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cell Death | 1 | 2014 | 267 | 0.110 |
Why?
|
| Digitoxin | 1 | 2013 | 7 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 1609 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2018 | 426 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2014 | 326 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 188 | 0.110 |
Why?
|
| Cytokines | 2 | 2023 | 602 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2014 | 366 | 0.100 |
Why?
|
| Vaccination | 2 | 2015 | 288 | 0.100 |
Why?
|
| Capsid | 1 | 2011 | 54 | 0.100 |
Why?
|
| Cross Reactions | 2 | 2008 | 83 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2011 | 110 | 0.100 |
Why?
|
| Peptides | 3 | 2013 | 320 | 0.100 |
Why?
|
| Chalcones | 1 | 2010 | 14 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 935 | 0.090 |
Why?
|
| Cottontail rabbit papillomavirus | 1 | 2010 | 1 | 0.090 |
Why?
|
| Human papillomavirus 18 | 1 | 2010 | 5 | 0.090 |
Why?
|
| Presenilin-1 | 1 | 2010 | 27 | 0.090 |
Why?
|
| Smoking | 1 | 2017 | 940 | 0.090 |
Why?
|
| Genitalia, Female | 1 | 2010 | 26 | 0.090 |
Why?
|
| Quinazolines | 2 | 2022 | 33 | 0.090 |
Why?
|
| Plant Extracts | 2 | 2004 | 286 | 0.090 |
Why?
|
| Lythraceae | 1 | 2009 | 3 | 0.090 |
Why?
|
| Xenopus laevis | 1 | 2009 | 73 | 0.090 |
Why?
|
| Proline | 1 | 2009 | 43 | 0.090 |
Why?
|
| Methylation | 1 | 2009 | 113 | 0.090 |
Why?
|
| Tissue Array Analysis | 2 | 2019 | 67 | 0.090 |
Why?
|
| Immunization, Secondary | 1 | 2008 | 8 | 0.080 |
Why?
|
| Injections, Subcutaneous | 1 | 2008 | 33 | 0.080 |
Why?
|
| Macaca | 1 | 2008 | 38 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2010 | 1518 | 0.080 |
Why?
|
| Thermodynamics | 1 | 2009 | 216 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 186 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 173 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 259 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 185 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2021 | 61 | 0.080 |
Why?
|
| Vaccines, DNA | 1 | 2007 | 23 | 0.080 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 1 | 2007 | 5 | 0.080 |
Why?
|
| Tumor Virus Infections | 1 | 2007 | 26 | 0.080 |
Why?
|
| Leucine Zippers | 1 | 2007 | 5 | 0.080 |
Why?
|
| COS Cells | 1 | 2007 | 69 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2010 | 933 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 275 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 11 | 0.070 |
Why?
|
| Fourier Analysis | 1 | 2006 | 43 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2006 | 62 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2007 | 304 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2006 | 87 | 0.070 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2007 | 107 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 132 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 448 | 0.060 |
Why?
|
| Phenylephrine | 1 | 2005 | 36 | 0.060 |
Why?
|
| Cadherins | 2 | 2016 | 90 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2005 | 48 | 0.060 |
Why?
|
| Gene Products, tat | 1 | 2004 | 35 | 0.060 |
Why?
|
| Garcinia | 1 | 2004 | 2 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 131 | 0.060 |
Why?
|
| Axonemal Dyneins | 1 | 2024 | 6 | 0.060 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2024 | 6 | 0.060 |
Why?
|
| Forecasting | 1 | 2004 | 128 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 286 | 0.060 |
Why?
|
| Anacardium | 1 | 2003 | 2 | 0.060 |
Why?
|
| Bleomycin | 1 | 2023 | 20 | 0.060 |
Why?
|
| Templates, Genetic | 1 | 2003 | 25 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 173 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 306 | 0.060 |
Why?
|
| Seeds | 1 | 2003 | 35 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 16 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 166 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2023 | 58 | 0.050 |
Why?
|
| Fruit | 1 | 2004 | 173 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2023 | 114 | 0.050 |
Why?
|
| Benzamides | 1 | 2003 | 78 | 0.050 |
Why?
|
| Prostate | 1 | 2024 | 154 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 859 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 540 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 515 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2022 | 133 | 0.050 |
Why?
|
| DNA Repair | 1 | 2022 | 188 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 356 | 0.050 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 132 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 222 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 36 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 2 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 7 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 1 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 38 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 11 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 36 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 74 | 0.040 |
Why?
|
| Quality of Life | 1 | 2024 | 481 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 144 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 53 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 149 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 73 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 115 | 0.040 |
Why?
|
| Alabama | 1 | 2018 | 51 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 251 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 10129 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 122 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 68 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 135 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 311 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2015 | 1908 | 0.040 |
Why?
|
| Femur Head | 1 | 2017 | 3 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 400 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2017 | 9 | 0.040 |
Why?
|
| Nitrosamines | 1 | 2017 | 10 | 0.040 |
Why?
|
| Butanones | 1 | 2017 | 5 | 0.040 |
Why?
|
| Azacitidine | 1 | 2017 | 22 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2017 | 50 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2017 | 22 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 113 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 1095 | 0.040 |
Why?
|
| Radiography | 1 | 2017 | 72 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2017 | 42 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 151 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 67 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 209 | 0.040 |
Why?
|
| Bone Density | 1 | 2017 | 75 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 219 | 0.040 |
Why?
|
| Biopsy | 1 | 2017 | 164 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 11712 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 65 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 190 | 0.030 |
Why?
|
| Benzo(a)pyrene | 1 | 2017 | 126 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 77 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 93 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 121 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 893 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 62 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 53 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 84 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 68 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 148 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 753 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 481 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 196 | 0.030 |
Why?
|
| Boronic Acids | 1 | 2013 | 19 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 336 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Pyrazines | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1492 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 11 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 6 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 898 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2013 | 49 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 44 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 37 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 150 | 0.030 |
Why?
|
| Luciferases | 1 | 2011 | 63 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 502 | 0.030 |
Why?
|
| Immunization | 1 | 2011 | 92 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 689 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2010 | 29 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 674 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1369 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 113 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 177 | 0.020 |
Why?
|
| Bovine papillomavirus 1 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Immune Sera | 1 | 2009 | 59 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 409 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 98 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 223 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 3483 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 74 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2008 | 43 | 0.020 |
Why?
|
| Biolistics | 1 | 2007 | 1 | 0.020 |
Why?
|
| Calreticulin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Rhodanine | 1 | 2007 | 2 | 0.020 |
Why?
|
| Acetyl Coenzyme A | 1 | 2007 | 7 | 0.020 |
Why?
|
| Tryptamines | 1 | 2007 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2007 | 19 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2008 | 64 | 0.020 |
Why?
|
| Papilloma | 1 | 2007 | 15 | 0.020 |
Why?
|
| Pineal Gland | 1 | 2007 | 31 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 550 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 864 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 238 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4268 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 265 | 0.020 |
Why?
|
| Melatonin | 1 | 2007 | 82 | 0.020 |
Why?
|
| Drug Design | 1 | 2007 | 162 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 389 | 0.020 |
Why?
|
| Skin | 1 | 2007 | 174 | 0.020 |
Why?
|
| United States | 1 | 2016 | 4223 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 308 | 0.020 |
Why?
|
| Binding Sites | 1 | 2007 | 651 | 0.020 |
Why?
|
| Urocortins | 1 | 2005 | 4 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2005 | 11 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 730 | 0.020 |
Why?
|
| Cell Size | 1 | 2005 | 44 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 1742 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 972 | 0.020 |
Why?
|
| Base Sequence | 1 | 2005 | 997 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 6741 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 1549 | 0.010 |
Why?
|